BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
BLCM
Delisted
BLCM was delisted on the 1st of June, 2023.
81 hedge funds and large institutions have $334M invested in Bellicum Pharmaceuticals, Inc. in 2015 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 41 increasing their positions, 16 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
65% less call options, than puts
Call options by funds: $983K | Put options by funds: $2.8M
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
81
Holding in Top 10
–
Calls
$983K
Puts
$2.8M
Top Buyers
| 1 | +$21.3M | |
| 2 | +$5.67M | |
| 3 | +$4.9M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$4.56M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$2.92M |
Top Sellers
| 1 | -$10.5M | |
| 2 | -$8.1M | |
| 3 | -$4.52M | |
| 4 |
RG
Redmile Group
San Francisco,
California
|
-$4.41M |
| 5 |
UBS AM
Chicago,
Illinois
|
-$2.08M |